August 2023
1. CAHILL EP
   Adding a COX-2 inhibitor improves efficacy of emergency contraception.
   Lancet. 2023 Aug 16:S0140-6736(23)01612-4. doi: 10.1016/S0140-6736(23)01612.
   

   >> Share

   
   
2. LI RHW, Lo SST, Gemzell-Danielsson K, Fong CHY, et al
   Oral emergency contraception with levonorgestrel plus piroxicam: a randomised double-blind placebo-controlled trial.
   Lancet. 2023 Aug 16:S0140-6736(23)01240-0. doi: 10.1016/S0140-6736(23)01240.
   

   >> Share

   
   June 2023
3. MARSTON C, Tabot M
   How can we put rights at the core of global family planning?
   Lancet. 2023;401:2096-2098.
   

   >> Share

   
   May 2023
4. MCCURRY J
   Japan approves abortion pill.
   Lancet. 2023;401:1558.
   

   >> Share

   
   April 2023
5. JAFFE S
   Drug developers caution against US mifepristone ban.
   Lancet. 2023;401:1325-1326.
   

   >> Share

   
   September 2022
6. DONNEZ J, Taylor HS, Stewart EA, Bradley L, et al
   Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials.
   Lancet. 2022;400:896-907.
   

   >> Share

   
   August 2022
7. ENDLER M, Petro G, Gemzell Danielsson K, Grossman D, et al
   A telemedicine model for abortion in South Africa: a randomised, controlled, non-inferiority trial.
   Lancet. 2022;400:670-679.
   

   >> Share

   
   July 2022
8. HAAKENSTAD A, Angelino O, Irvine CMS, Bhutta ZA, et al
   Measuring contraceptive method mix, prevalence, and demand satisfied by age and marital status in 204 countries and territories, 1970-2019: a systematic analysis for the Global Burden of Disease Study 2019.
   Lancet. 2022;400:295-327.
   

   >> Share

   
   
9. PRADHAN MR
   Contraceptive mix and informed choice.
   Lancet. 2022;400:255-257.
   

   >> Share

   
   
10. HIAM L, Mateescu I, Spiegel P
    Improving access to contraception and abortion in Romania in the context of the conflict in Ukraine.
    Lancet. 2022 Jul 8. pii: S0140-6736(22)01275.
    

    >> Share

    
    June 2022
11. BARTZ D
    Incidence of perforation with intrauterine devices.
    Lancet. 2022;399:2076-2077.
    

    >> Share

    
    April 2022
12. DELANY-MORETLWE S, Hughes JP, Bock P, Ouma SG, et al
    Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial.
    Lancet. 2022 Apr 1. pii: S0140-6736(22)00538.
    

    >> Share

    
    July 2021
13. HOLT E
    Compensation for victims of sterilisation.
    Lancet. 2021;398:378.
    

    >> Share

    
    
14. WARASNA B, Rajabi N, Mustafa B, Najjar A, et al
    Knowledge and attitude of Palestinian women to contraceptives: a cross-sectional study.
    Lancet. 2021;398 Suppl 1:S45.
    

    >> Share

    
    November 2020
15. CAMERON ST, Glasier A, McDaid L, Radley A, et al
    Use of effective contraception following provision of the progestogen-only pill for women presenting to community pharmacies for emergency contraception (Bridge-It): a pragmatic cluster-randomised crossover trial.
    Lancet. 2020;396:1585-1594.
    

    >> Share

    
    
16. MARSTON C, Sowemimo A
    Bridge-It trial-a step towards better contraception services.
    Lancet. 2020;396:1536-1537.
    

    >> Share

    
    August 2020
17. CHU JJ, Devall AJ, Beeson LE, Hardy P, et al
    Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial.
    Lancet. 2020 Aug 24. pii: S0140-6736(20)31788.
    

    >> Share

    
    
18. BARNHART K
    Medical management of miscarriage with mifepristone.
    Lancet. 2020 Aug 24. pii: S0140-6736(20)31789.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share